Search Ontology:
ChEBI

grazoprevir

Term ID
CHEBI:132975
Synonyms
  • (1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]qui
  • grazoprevir
  • MK 5172
Definition
An azamacrocyclic compound that is a hepatitis C protease inhibitor used in combination with elbasvir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults.
References
  • cas:1350514-68-9
  • drugcentral:5081
  • pmc:PMC4135988
  • pubmed:24666106
  • pubmed:24727022
  • pubmed:25266288
  • pubmed:25467560
  • pubmed:25467591
  • pubmed:26353843
  • pubmed:26423374
  • pubmed:26532861
  • pubmed:26682473
  • pubmed:26818134
  • pubmed:26849059
  • pubmed:26926625
  • pubmed:26933896
  • pubmed:26938699
  • pubmed:26943930
  • pubmed:27091555
  • pubmed:27123552
  • pubmed:27291249
  • pubmed:27403342
  • pubmed:27418810
  • reaxys:19999739
  • wikipedia.en:Grazoprevir
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from grazoprevir
Phenotype where environments contain grazoprevir
Phenotype modified by environments containing grazoprevir
Phenotype affecting grazoprevir
Human Disease Model